Business
PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
PAVmed Inc. (NASDAQ: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today provided a business update for the Company and its subsidiaries, Lucid Diagnostics Inc. (NASDAQ: LUCD) ("Lucid") and Veris Health Inc. ("Veris"), and reported financial results for the fourth quarter and year ended December 31, 2025.
About this update from Pavmed Inc.
[{"type":"text","content":"PAVmed strengthened its capital structure and relaunched its medical device portfolio under new leadership ","length":106,"tagName":"p","attribs":{}},{"type":"text","content":"Veris Health advanced strategic partnership with OSU and progressed implantable physiological monitor toward FDA submission","length":123,"tagName":"p","attribs":{}},{"type":"text","content":"Lucid Diagnostics expanded EsoGuard healthcare system access and clinical evidence base ","length":87,"tagName":"p","attribs":{}},{"type":"text","content":"Conference call and webcast to be held today, March 30, at 8:30 AM EST","length":70,"tagName":"p","attribs":{}},{"type":"text","content":"NEW YORK, March 30, 2026 /PRNewswire/ -- PAVmed Inc. (NASDAQ: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today provided a business update for the Company and its subsidiaries, Lucid Diagnostics Inc. (NASDAQ: LUCD) ("Lucid") and Veris Health Inc. ("Veris"), and reported financial results for the fourth quarter and year ended December 31, 2025.","length":514,"tagName":"p"},{"type":"image","alt":"PAVmed Inc. is a diversified commercial-stage medical technology company operating in the medical device, diagnostics, and digital health sectors. (PRNewsfoto/PAVmed Inc.)","displaySize":"","headline":null,"caption":"PAVmed Inc. is a diversified commercial-stage medical technology company operating in the medical device, diagnostics, and digital health sectors. (PRNewsfoto/PAVmed Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":81,"url":"https://media.zenfs.com/en/prnewswire.com/b33818e0ad32f6b512ca93166f23ff80"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/kkK20uZJNED_IOvxDV4XCA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTE0Mw--/https://media.zenfs.com/en/prnewswire.com/b33818e0ad32f6b512ca93166f23ff80","width":400,"height":81}},"href":"https://mma.prnewswire.com/media/2011714/PAVmed_updated_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Conference Call and Webcast","length":27,"tagName":"p"},{"type":"text","content":"The webcast will take place on Monday, March 30, 2026, at 8:30 AM and is accessible in the investor relations section of the Comp...